Drugs / abacavir/lamivudine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01900106 | Nov 2013 → Dec 2017 | HIV infectious disease | University of Modena and Reggio Emilia | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | abacavir/lamivudine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01900106 ↗ |
| Route | Oral | “Administration: oral” NCT01900106 ↗ |